long term side effects of glp-1 for weight loss The Long-Term Drugs: What We Know So Far What to Expect During the

Keywords: GLP-1 receptor agonists, Type-2 diabetes, Obesity, Metabolic disorders, Cardiovascular protection, Drug development Introduction GLP-1 is an endogenous incretin hormone produced by intestinal L-cells that modulates postprandial glucose levels via glucose-dependent insulin production, offering intrinsic protection against hypoglycemia (Zander et al

For most people, this is not a willpower problem

Perceptions of obesity among healthcare professionals and policy makers in 2023: results of the global OPEN survey

Purpose-built for physicians GLP-1 receptor agonist prescriptions for obesity have risen in those without diabetes Key takeaways: Semaglutide was the highest newly prescribed GLP-1 receptor agonist in 2023